|
- 积分
- 1
- 威望
- 1
- 包包
- 292
|
When Nature broke the news in December 2011 that Novartis$ I9 |; R+ ~% l y6 Z/ c
was to close its brain research facility in Basel, Switzerland,( M+ |! \7 Z, b d# b/ {+ T0 l% h
the story noted that this move closely followed similar cuts
7 m5 z+ s8 \0 Iby rival pharmaceutical firms. As a report from the European College \; e" d- E: e5 _
of Neuropsychopharmacology
# K( u: N5 b7 z1 D% Hhad warned a few months earlier, the5 o& g- o7 T2 C: Q/ P4 t0 U
abandonment of research into new psychiatric drugs by AstraZeneca,/ u B+ _0 R' B9 I4 ?0 ^ A
GlaxoSmithKline
% P+ f" o0 R- u: ]' V# P% vand others meant that “withdrawal of research
* e. S1 P. R! Z' k$ ]8 l" \4 \$ yresources is a withdrawal of hope for patients and their families”.
7 w$ A5 Q& a G* K/ m9 C2 k) ~7 [7 d3 x* E+ {- r/ y, r6 l0 W
; L. @+ o8 Y0 M' L* s
回复有免费下载链接( B2 F7 @7 u: ^! E# I
) @. \% F* T; X7 g5 ~ |
-
总评分: 包包 + 20
查看全部评分
|
发表于 2013-10-12 08:22
发表于 2013-10-12 08:44
